Characteristics of Devic's disease (neuromyelitis optica) in Mexico

Journal of Neurology

Volumn 255, Issue 5, 2008, Pages 710-715

  Rivera, J F ^a   Kurtzke, J F ^b   Booth, V J A ^a   Corona V, T ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune disease; Demyelinating diseases; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEXICO; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

ADULT; AGE OF ONSET; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEXICO; NEUROMYELITIS OPTICA; OPTIC NERVE; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPINAL CORD; VISION, LOW;

EID: 44449090957     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0781-2     Document Type: Article

References (29)

1. Arruda WO, Scola RH, Teive HA, Werneck LC (2001) Multiple sclerosis: report of 200 cases from Curitiba, southern Brazil and comparison with other Brazilian series. Arq Neuropsiquiatr 59:165-170
2. Cabre P, Heinzlef O, Merle H, Buisson GG, Bera O, Bellance R (2001) MS and neuromyelitis optica in Martinique (French West Indies). Neurology 56:507-514
3. Corona T, Roman GC (2006) Multiple sclerosis in Latin America. Neuroepidemiology 26:1-3
4. re session, Lyon (cited by Gault [6])
5. Fazekas F, Offenbacher H, Schmidt R, Strasser-Fuchs S (1994) MRI of neuromyelitis optica: evidence for a distinct entity (letter). J Neurol Neurosurg Psychiatr 57:1140-1142
6. Gault F (1894) De La Neuromyélite Optique Aiguë. Thèse. Lyon; Alexandre Rey, Imprimeur de la Faculté de Médicine. Novembre 1894 (p 104)
7. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E (2004) Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol 251:47-52
8. Guthrie TC, Kurtzke JF, Berlin L (1952) Acute respiratory failure in multiple sclerosis and its management. Ann Int Med 37:1197-1203
9. Jacobs D, Roemer S, Weinshenker B, Pittock S, Wingerchuk D, Lennon V, Lucchinetti CF (2006) The pathology of brain involvement in neuromyelitis optica spectrum disorders. Mult Scler 12:S155 (abstract)
10. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T, Toyokura Y (1975) Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1, 084 cases. Neurology 25:845-851
11. Kurtzke JF (1970) Clinical manifestations of multiple sclerosis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. North-Holland Publ Co, Amsterdam, pp 161-216
12. Kurtzke JF (1975) A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand 51:110-136
13. Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
14. th Annual Meeting, Chicago, IL, p 11
15. Lennon VA, Kryzer TJ, Pittock SJ, Verkmann AS, Hinson S (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477
16. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112
17. Mandler RN, Davis LE, Jeffery DR, Korn feld M (1993) Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162-168
18. Nelson LM, McGuire VM (2004) Study design, measures of effect, and sources of bias. In: Nelson LM, Tanner CM, Van Den Eeden SK, McGuire VM (eds) Neuroepidemiology. From Principles to Practice. Oxford University Press, Oxford, pp 23-54
19. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Miller DH (1996) Clinical, CSF and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatr 60:382-387
20. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, de Almeida AMV, Oliveira S, Basilio De Oliveira CA, et al. (2002) Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 73:429-435
21. Patrucco LB, Cristiano E, Videla GC, Bauso Toselli PL (2002) Devic's neuromyelitis optica (NMO) and multiple sclerosis (MS): clinical and epidemiologic findings in an MS center in Argentina. Multiple Sclerosis 8(Suppl):S37 (abstract)
22. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
23. Reindl M, Khalil M, Berger T (2006) Antibodies as biological markers for pathophysiological processes in MS. J Neuroimmunol 180:50-62
24. Scolding N (2001) The differential diagnosis of multiple sclerosis. Neurology in Practice 71(Suppl 2):9-15
25. Scolding N (2005) Devic's disease and autoantibodies. Lancet Neurology 4:136-137
26. Singhal BS (1985) Multiple sclerosis - Indian experience. Ann Acad Med, Singapore 14:32-36
27. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107-1114
28. Wingerchuk DM, Lennon VA, Pittock SS, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485-1489
29. Wright JW (2006) In: Wright J (ed) The New York Times 2006 Almanac. New York, Penguin Books, pp 630-631